| chromatin modification | GO:0016568 | 187 | 0.970 | Human Mouse Worm |
| protein acylation | GO:0043543 | 64 | 0.969 | Human Mouse Worm |
| covalent chromatin modification | GO:0016569 | 163 | 0.964 | Human Mouse Worm |
| histone acetylation | GO:0016573 | 41 | 0.963 | Human Mouse Worm |
| chromatin organization | GO:0006325 | 206 | 0.952 | Human Mouse Worm |
| peptidyl lysine modification | GO:0018205 | 77 | 0.944 | Human Mouse Worm |
| dna metabolic process | GO:0006259 | 303 | 0.899 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.881 | Human Mouse Worm |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.824 | Human Mouse Worm |
| histone modification | GO:0016570 | 159 | 0.753 | Human Mouse Worm |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.745 | Human |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.707 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.706 | |
| histone h4 acetylation | GO:0043967 | 10 | 0.688 | Human |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.681 | |
| gene silencing | GO:0016458 | 38 | 0.669 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.669 | |
| cellular response to radiation | GO:0071478 | 28 | 0.657 | |
| histone h3 acetylation | GO:0043966 | 14 | 0.651 | |
| methylation | GO:0032259 | 134 | 0.650 | |
| amine metabolic process | GO:0009308 | 45 | 0.630 | |
| regulation of histone modification | GO:0031056 | 56 | 0.616 | |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.603 | Human Mouse Worm |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.562 | |
| response to uv | GO:0009411 | 44 | 0.550 | |
| protein methylation | GO:0006479 | 81 | 0.543 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.536 | |
| regulation of response to drug | GO:2001023 | 2 | 0.536 | |
| embryonic placenta development | GO:0001892 | 98 | 0.529 | |
| male gamete generation | GO:0048232 | 285 | 0.523 | Worm |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.501 | |
| cellular response to light stimulus | GO:0071482 | 19 | 0.500 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.500 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.499 | |
| response to oxidative stress | GO:0006979 | 123 | 0.497 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.494 | |
| placenta development | GO:0001890 | 140 | 0.488 | |
| lipid phosphorylation | GO:0046834 | 25 | 0.462 | |
| phosphatidylinositol phosphorylation | GO:0046854 | 23 | 0.439 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.429 | Human Mouse Worm |
| regulation of chromatin modification | GO:1903308 | 57 | 0.412 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.405 | |
| response to radiation | GO:0009314 | 165 | 0.404 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.394 | |
| gland development | GO:0048732 | 330 | 0.394 | |
| oxidation reduction process | GO:0055114 | 342 | 0.382 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.380 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.373 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.365 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.365 | |
| hexose metabolic process | GO:0019318 | 98 | 0.355 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.354 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.351 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.345 | |
| response to inorganic substance | GO:0010035 | 96 | 0.335 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.334 | Human |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.325 | Human |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.316 | |
| spermatogenesis | GO:0007283 | 284 | 0.316 | Worm |
| protein alkylation | GO:0008213 | 81 | 0.307 | |
| response to acid chemical | GO:0001101 | 111 | 0.298 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.294 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.291 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.290 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.288 | |
| genetic imprinting | GO:0071514 | 27 | 0.288 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.283 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.283 | |
| response to testosterone | GO:0033574 | 3 | 0.278 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.271 | |
| negative regulation of cell size | GO:0045792 | 3 | 0.270 | |
| macromolecule methylation | GO:0043414 | 120 | 0.267 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.265 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.262 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.259 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.254 | |
| limb morphogenesis | GO:0035108 | 149 | 0.254 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.252 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.248 | |
| phosphatidylinositol 3 phosphate biosynthetic process | GO:0036092 | 6 | 0.246 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.244 | |
| chromatin silencing | GO:0006342 | 15 | 0.238 | |
| t cell differentiation | GO:0030217 | 174 | 0.237 | |
| regulation of genetic imprinting | GO:2000653 | 5 | 0.225 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.219 | |
| glucose metabolic process | GO:0006006 | 92 | 0.213 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.212 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.212 | |
| response to light stimulus | GO:0009416 | 135 | 0.209 | |
| negative regulation of chromatin silencing | GO:0031936 | 1 | 0.209 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.209 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.205 | |
| dna repair | GO:0006281 | 107 | 0.205 | |
| histone lysine methylation | GO:0034968 | 50 | 0.203 | |
| respiratory tube development | GO:0030323 | 167 | 0.203 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.200 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.198 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.196 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.193 | |
| regulation of cell size | GO:0008361 | 72 | 0.189 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.189 | |
| germ cell development | GO:0007281 | 185 | 0.187 | Worm |
| histone methylation | GO:0016571 | 71 | 0.185 | |
| appendage development | GO:0048736 | 166 | 0.184 | |
| dendrite development | GO:0016358 | 115 | 0.179 | |
| dna methylation | GO:0006306 | 43 | 0.179 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.178 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.178 | |
| neural tube development | GO:0021915 | 160 | 0.176 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.172 | |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.170 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.168 | |
| developmental maturation | GO:0021700 | 193 | 0.167 | |
| regulation of cellular response to drug | GO:2001038 | 1 | 0.164 | |
| response to drug | GO:0042493 | 75 | 0.162 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.161 | |
| regionalization | GO:0003002 | 337 | 0.159 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.154 | |
| response to peptide | GO:1901652 | 136 | 0.153 | |
| multicellular organism growth | GO:0035264 | 161 | 0.152 | |
| cellular response to nitric oxide | GO:0071732 | 4 | 0.152 | |
| camera type eye development | GO:0043010 | 266 | 0.151 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.149 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.148 | |
| protein maturation | GO:0051604 | 176 | 0.146 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.146 | |
| response to oxygen levels | GO:0070482 | 62 | 0.144 | Human |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.140 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.138 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.137 | |
| neural tube formation | GO:0001841 | 108 | 0.137 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.136 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.136 | |
| limb development | GO:0060173 | 166 | 0.136 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.134 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.133 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.131 | |
| chromatin remodeling | GO:0006338 | 32 | 0.129 | |
| response to metal ion | GO:0010038 | 47 | 0.129 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.128 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.127 | |
| telencephalon development | GO:0021537 | 186 | 0.126 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.126 | |
| maintenance of location | GO:0051235 | 89 | 0.126 | Worm |
| intracellular steroid hormone receptor signaling pathway | GO:0030518 | 29 | 0.125 | Human |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.125 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.125 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.125 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.124 | |
| lung development | GO:0030324 | 164 | 0.123 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.123 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.121 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.121 | Human |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.120 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 19 | 0.120 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.119 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.118 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.118 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.118 | |
| phosphatidylinositol biosynthetic process | GO:0006661 | 15 | 0.116 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.115 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.114 | |
| response to steroid hormone | GO:0048545 | 56 | 0.114 | Human |
| chromatin mediated maintenance of transcription | GO:0048096 | 2 | 0.111 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.111 | |
| epithelial cell development | GO:0002064 | 159 | 0.111 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.110 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.110 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.108 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.107 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.107 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.107 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.107 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.107 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.106 | Human |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.105 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.103 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.103 | |
| muscle cell apoptotic process | GO:0010657 | 18 | 0.103 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.103 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.103 | |
| regulation of muscle cell apoptotic process | GO:0010660 | 17 | 0.102 | |
| myotube differentiation | GO:0014902 | 105 | 0.102 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.101 | Human |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.100 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.100 | |
| digestive tract development | GO:0048565 | 190 | 0.100 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.100 | |
| neuron death | GO:0070997 | 154 | 0.099 | |
| double strand break repair | GO:0006302 | 48 | 0.098 | |
| response to insulin | GO:0032868 | 100 | 0.097 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 43 | 0.097 | |
| positive regulation of chromosome organization | GO:2001252 | 33 | 0.096 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.096 | |
| stem cell development | GO:0048864 | 219 | 0.096 | Mouse |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.095 | |
| female sex differentiation | GO:0046660 | 84 | 0.095 | |
| negative regulation of cell aging | GO:0090344 | 5 | 0.095 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.095 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.094 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.094 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.094 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.092 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.091 | |
| spermatid differentiation | GO:0048515 | 115 | 0.091 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.090 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.089 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.089 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.088 | |
| tube formation | GO:0035148 | 140 | 0.088 | |
| regulation of neuron death | GO:1901214 | 134 | 0.088 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.087 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.087 | |
| cell maturation | GO:0048469 | 127 | 0.087 | |
| cellular response to drug | GO:0035690 | 15 | 0.086 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.086 | |
| heart contraction | GO:0060047 | 93 | 0.086 | |
| positive regulation of transcription by galactose | GO:0000411 | 1 | 0.086 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.086 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.085 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.085 | Human |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.083 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.082 | |
| angiogenesis | GO:0001525 | 201 | 0.082 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.082 | |
| protein oligomerization | GO:0051259 | 67 | 0.082 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.082 | |
| female gamete generation | GO:0007292 | 74 | 0.082 | Worm |
| negative regulation of growth | GO:0045926 | 99 | 0.082 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.082 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.082 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.081 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.081 | |
| protein ubiquitination | GO:0016567 | 171 | 0.080 | |
| skeletal system development | GO:0001501 | 356 | 0.079 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.079 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.079 | |
| protein catabolic process | GO:0030163 | 221 | 0.079 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.079 | |
| regulation of autophagy | GO:0010506 | 30 | 0.079 | |
| regulation of binding | GO:0051098 | 111 | 0.078 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.078 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.077 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.076 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.076 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.076 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.076 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.076 | |
| regulation of transcription from rna polymerase ii promoter by galactose | GO:0000431 | 1 | 0.075 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.075 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.074 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.074 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.074 | |
| neuron maturation | GO:0042551 | 29 | 0.073 | |
| cellular response to oxygen levels | GO:0071453 | 20 | 0.073 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.072 | |
| muscle cell development | GO:0055001 | 133 | 0.072 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.072 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.072 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.071 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.070 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.070 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.070 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.069 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.069 | |
| regulation of protein stability | GO:0031647 | 52 | 0.069 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.069 | |
| negative regulation of cellular senescence | GO:2000773 | 3 | 0.069 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.069 | |
| protein processing | GO:0016485 | 163 | 0.069 | |
| protein import | GO:0017038 | 101 | 0.068 | |
| gastrulation | GO:0007369 | 116 | 0.068 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.068 | |
| response to alcohol | GO:0097305 | 48 | 0.067 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.067 | |
| response to hypoxia | GO:0001666 | 58 | 0.067 | Human |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.067 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.067 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.066 | |
| embryonic hemopoiesis | GO:0035162 | 23 | 0.066 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.066 | |
| cellular response to peptide | GO:1901653 | 92 | 0.066 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.066 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.065 | |
| cellular response to lipid | GO:0071396 | 145 | 0.065 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.065 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.065 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.064 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.064 | |
| protein localization to organelle | GO:0033365 | 185 | 0.063 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.063 | |
| response to purine containing compound | GO:0014074 | 28 | 0.063 | |
| response to nutrient levels | GO:0031667 | 109 | 0.062 | |
| fat cell differentiation | GO:0045444 | 160 | 0.062 | |
| stem cell differentiation | GO:0048863 | 268 | 0.062 | Mouse |
| response to heat | GO:0009408 | 27 | 0.062 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.062 | |
| blastocyst development | GO:0001824 | 80 | 0.061 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.061 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 7 | 0.061 | |
| response to peptide hormone | GO:0043434 | 127 | 0.061 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.061 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.061 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.061 | |
| muscle fiber development | GO:0048747 | 76 | 0.061 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.060 | |
| regulation of zinc ion transport | GO:0071579 | 2 | 0.060 | |
| neural tube closure | GO:0001843 | 90 | 0.060 | |
| primary neural tube formation | GO:0014020 | 95 | 0.059 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.059 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.059 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.059 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.058 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.058 | |
| positive regulation of endopeptidase activity | GO:0010950 | 43 | 0.058 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.058 | |
| t cell activation | GO:0042110 | 289 | 0.058 | |
| positive regulation of binding | GO:0051099 | 49 | 0.058 | |
| digestive system development | GO:0055123 | 200 | 0.057 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.057 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.057 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.057 | |
| nucleosome disassembly | GO:0006337 | 1 | 0.057 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.057 | |
| defense response to other organism | GO:0098542 | 197 | 0.057 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.057 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.056 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.056 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.056 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.056 | |
| axonogenesis | GO:0007409 | 274 | 0.055 | |
| cytokine production | GO:0001816 | 319 | 0.055 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.055 | |
| clathrin coat assembly | GO:0048268 | 2 | 0.055 | |
| glucose homeostasis | GO:0042593 | 128 | 0.054 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.054 | |
| epithelial tube formation | GO:0072175 | 130 | 0.054 | |
| oogenesis | GO:0048477 | 56 | 0.054 | Worm |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.054 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.053 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.053 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.053 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.053 | |
| lipid modification | GO:0030258 | 65 | 0.053 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.053 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.053 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.053 | Worm |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.052 | |
| regulation of protein import into nucleus | GO:0042306 | 52 | 0.052 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.052 | |
| dna recombination | GO:0006310 | 92 | 0.052 | |
| positive regulation of histone modification | GO:0031058 | 28 | 0.052 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.052 | |
| positive regulation of glucose metabolic process | GO:0010907 | 21 | 0.051 | |
| regulation of cellular response to insulin stimulus | GO:1900076 | 30 | 0.051 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.050 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.050 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.050 | |
| regulation of cell motility | GO:2000145 | 236 | 0.050 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.050 | |
| lipid homeostasis | GO:0055088 | 63 | 0.049 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.049 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.049 | |
| respiratory system development | GO:0060541 | 190 | 0.049 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.048 | |
| regulation of protein localization | GO:0032880 | 231 | 0.048 | |
| rhythmic process | GO:0048511 | 174 | 0.048 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.048 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.048 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.048 | |
| b cell homeostasis | GO:0001782 | 34 | 0.047 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.047 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.047 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.047 | |
| heart morphogenesis | GO:0003007 | 178 | 0.046 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.046 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.046 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.046 | |
| carbon catabolite regulation of transcription | GO:0045990 | 4 | 0.046 | |
| negative regulation of myeloid leukocyte differentiation | GO:0002762 | 20 | 0.046 | |
| organelle fission | GO:0048285 | 170 | 0.046 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.045 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.045 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.045 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.045 | Human |
| granulocyte differentiation | GO:0030851 | 17 | 0.045 | |
| negative regulation of cellular response to insulin stimulus | GO:1900077 | 16 | 0.045 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.045 | |
| mrna metabolic process | GO:0016071 | 84 | 0.044 | |
| innate immune response | GO:0045087 | 157 | 0.044 | |
| regulation of transcription from rna polymerase ii promoter in response to stress | GO:0043618 | 8 | 0.044 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.044 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.043 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.043 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.043 | |
| cellular response to starvation | GO:0009267 | 57 | 0.043 | |
| blood circulation | GO:0008015 | 195 | 0.043 | |
| forebrain development | GO:0030900 | 302 | 0.043 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 47 | 0.043 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.043 | |
| feeding behavior | GO:0007631 | 62 | 0.043 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.042 | |
| phagocytosis | GO:0006909 | 66 | 0.042 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.042 | |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 10 | 0.041 | |
| gonad development | GO:0008406 | 141 | 0.041 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.041 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.041 | |
| ovulation cycle | GO:0042698 | 59 | 0.041 | |
| body morphogenesis | GO:0010171 | 45 | 0.041 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.041 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.041 | |
| male sex differentiation | GO:0046661 | 109 | 0.040 | |
| response to growth factor | GO:0070848 | 198 | 0.040 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.040 | |
| carbon catabolite regulation of transcription from rna polymerase ii promoter | GO:0000429 | 4 | 0.040 | |
| macroautophagy | GO:0016236 | 21 | 0.040 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.040 | |
| cation homeostasis | GO:0055080 | 212 | 0.040 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.039 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.039 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.039 | Human |
| female gonad development | GO:0008585 | 71 | 0.039 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.039 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.039 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.039 | |
| defense response to bacterium | GO:0042742 | 119 | 0.039 | |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.039 | |
| regulation of secretion | GO:0051046 | 274 | 0.039 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.039 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.039 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.039 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.038 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.038 | |
| regulation of protein transport | GO:0051223 | 163 | 0.038 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.038 | |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.038 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.038 | |
| stress activated protein kinase signaling cascade | GO:0031098 | 81 | 0.038 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.038 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.038 | |
| muscle tissue development | GO:0060537 | 308 | 0.037 | |
| cell aging | GO:0007569 | 35 | 0.037 | |
| bone morphogenesis | GO:0060349 | 78 | 0.037 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.037 | |
| phosphatidylinositol metabolic process | GO:0046488 | 45 | 0.037 | |
| amide transport | GO:0042886 | 138 | 0.037 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.036 | |
| locomotory behavior | GO:0007626 | 195 | 0.036 | |
| regulation of protein processing | GO:0070613 | 96 | 0.036 | |
| response to fatty acid | GO:0070542 | 8 | 0.036 | |
| glucan metabolic process | GO:0044042 | 32 | 0.036 | |
| liver development | GO:0001889 | 66 | 0.036 | |
| mesoderm development | GO:0007498 | 100 | 0.036 | |
| oocyte differentiation | GO:0009994 | 35 | 0.036 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.036 | |
| regulation of protein acetylation | GO:1901983 | 22 | 0.035 | |
| regulation of organ growth | GO:0046620 | 61 | 0.035 | |
| sensory perception | GO:0007600 | 245 | 0.035 | |
| negative regulation of gene silencing | GO:0060969 | 2 | 0.035 | |
| cellular response to reactive nitrogen species | GO:1902170 | 5 | 0.035 | |
| hindbrain development | GO:0030902 | 128 | 0.035 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.035 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.035 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.035 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.034 | |
| endocrine system development | GO:0035270 | 98 | 0.034 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.034 | |
| respiratory system process | GO:0003016 | 25 | 0.034 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.034 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.034 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.034 | |
| positive regulation of cellular carbohydrate metabolic process | GO:0010676 | 29 | 0.034 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.034 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.033 | |
| regulation of ossification | GO:0030278 | 112 | 0.033 | |
| response to oxygen radical | GO:0000305 | 16 | 0.033 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.033 | |
| single organism nuclear import | GO:1902593 | 95 | 0.033 | |
| wound healing | GO:0042060 | 157 | 0.033 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.033 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.033 | |
| adaptive immune response | GO:0002250 | 155 | 0.033 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.033 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.033 | |